These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18846036)

  • 1. Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions.
    Trevethick MA; Mantell SJ; Stuart EF; Barnard A; Wright KN; Yeadon M
    Br J Pharmacol; 2008 Oct; 155(4):463-74. PubMed ID: 18846036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
    Chung KF; Caramori G; Adcock IM
    Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an inhaled adenosine A2A agonist on the allergen-induced late asthmatic response.
    Luijk B; van den Berge M; Kerstjens HA; Postma DS; Cass L; Sabin A; Lammers JW
    Allergy; 2008 Jan; 63(1):75-80. PubMed ID: 17944983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal administration of NECA can induce both anti-inflammatory and pro-inflammatory effects in BALB/c mice: evidence for A 2A receptor sub-type mediation of NECA-induced anti-inflammatory effects.
    El-Hashim AZ; Abduo HT; Rachid OM; Luqmani YA; Al Ayadhy BY; Alkhaledi GM
    Pulm Pharmacol Ther; 2009 Jun; 22(3):243-52. PubMed ID: 19146972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A2A Adenosine Receptor Agonists and their Potential Therapeutic Applications. An Update.
    Guerrero A
    Curr Med Chem; 2018; 25(30):3597-3612. PubMed ID: 29532748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.
    Gazoni LM; Walters DM; Unger EB; Linden J; Kron IL; Laubach VE
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):440-6. PubMed ID: 20398911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled adenosine A(2A) receptor agonists for the treatment of chronic obstructive pulmonary disease.
    Mantell SJ; Stephenson PT; Monaghan SM; Maw GN; Trevethick MA; Yeadon M; Keir RF; Walker DK; Jones RM; Selby MD; Batchelor DV; Rozze S; Chavaroche H; Hobson TJ; Dodd PG; Lemaitre A; Wright KN; Stuart EF
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1284-7. PubMed ID: 18243699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine receptors and asthma.
    Brown RA; Spina D; Page CP
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S446-56. PubMed ID: 18311158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finding better therapeutic targets for patients with asthma: adenosine receptors?
    Polosa R
    Br J Pharmacol; 2008 Oct; 155(4):441-3. PubMed ID: 18852692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and application of locally delivered agonists of the adenosine A(2A) receptor.
    Mantell S; Jones R; Trevethick M
    Expert Rev Clin Pharmacol; 2010 Jan; 3(1):55-72. PubMed ID: 22111533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease.
    Spears M; McSharry C; Thomson NC
    Clin Exp Allergy; 2006 Dec; 36(12):1494-504. PubMed ID: 17177672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SAR of a series of inhaled A(2A) agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data.
    Mantell SJ; Stephenson PT; Monaghan SM; Maw GN; Trevethick MA; Yeadon M; Walker DK; Selby MD; Batchelor DV; Rozze S; Chavaroche H; Lemaitre A; Wright KN; Whitlock L; Stuart EF; Wright PA; Macintyre F
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4471-5. PubMed ID: 19501510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting adenosine receptors: novel therapeutic targets in asthma and chronic obstructive pulmonary disease.
    Rorke S; Holgate ST
    Am J Respir Med; 2002; 1(2):99-105. PubMed ID: 14720064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD.
    Shute JK; Puxeddu E; Calzetta L
    Curr Opin Pharmacol; 2018 Jun; 40():39-45. PubMed ID: 29455115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine and adenosine receptors: their contribution to airway inflammation and therapeutic potential in asthma.
    Caruso M; Varani K; Tringali G; Polosa R
    Curr Med Chem; 2009; 16(29):3875-85. PubMed ID: 19747135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of adenosine receptors in the treatment of asthma and chronic obstructive pulmonary disease: recent developments.
    van den Berge M; Hylkema MN; Versluis M; Postma DS
    Drugs R D; 2007; 8(1):13-23. PubMed ID: 17249846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary diseases in the elderly. Problems of pharmacotherapy].
    Ukena D
    Internist (Berl); 2003 Aug; 44(8):995-1002. PubMed ID: 14671814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
    Ding B; Small M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.